Skip to main content

Beta blockers in premedication of the cardiac patient — a must in 2003?!

  • Conference paper
Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.
  • 180 Accesses

Abstract

Myocardial cardiac events are the most common medical complication of surgery, occurring in 2–5% of patients undergoing noncardiac surgery and as many as 30% of patients undergoing vascular surgery. Perioperative cardiac events are associated with a mortality rate of nearly 60% per event, prolonged hospitalisation, and high costs [1, 2]. One study found that postoperative ischaemia increased the odds of postoperative myocardial events 21-fold [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mangano DT, Wong MG, London MJ et al (1991) Perioperative myocardial ischemia in patients undergoing noncardiac surgery. I. Incidence and severity during the 1st week after surgery. The Study of Perioperative Ischemia ( SPI) Research Group. J Am Coll Cardiol 17: 851–857

    Article  PubMed  CAS  Google Scholar 

  2. Mangano DT, Browner WS, Hollenberg M et al (1990) Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 323: 1781–1788

    Article  PubMed  CAS  Google Scholar 

  3. Landesberg G, Luria MH, Cotev S et al (1993) Importance of long-duration postoperative ST segment depression in cardiac morbidity after vascular surgery. Lancet 341: 715–719

    Article  PubMed  CAS  Google Scholar 

  4. Warltier DC (1998) Beta-adrenergic-blocking drugs: incredibly useful, incredibly underutilized. Anesthesiology 88: 2–5

    Article  PubMed  CAS  Google Scholar 

  5. Prys-Roberts C, Foex P, Biro GP et al (1973) Studies of anaesthesia in relation to hypertension. V. Adrenergic beta-receptor blockade. Br J Anaesth 45: 671–681

    Article  Google Scholar 

  6. Smulyan H, Weinberg SE, Howanitz PJ (1982) Continuous propranolol infusion following abdominal surgery. JAMA 247: 2539–2542

    Article  PubMed  CAS  Google Scholar 

  7. Slogoff S, Keats AS (1986) Further observations on perioperative myocardial ischemia. Anesthesiology 65: 539–542

    Article  PubMed  CAS  Google Scholar 

  8. Slogoff S, Keats AS (1985) Does perioperative myocardial ischemia lead to postoperative myocardial infarction? Anesthesiology 62: 107–114

    Article  PubMed  CAS  Google Scholar 

  9. Atkinson RS, Rushman GB, Lee JA (1987) A synopsis of anaesthesia, 10th edn. Wright, Bristol

    Google Scholar 

  10. Zaugg M, Jamali NZ, Lucchinetti E et al (2000) Norepinephrine-induced apoptosis is inhibited in adult rat ventricular myocytes exposed to volatile anesthetics. Anesthesiology 93: 209–218

    Article  PubMed  CAS  Google Scholar 

  11. Pasternack PF, Imparato AM, Baumann FG et al (1987) The hemodynamics of beta-blockade in patients undergoing abdominal aortic aneurysm repair. Circulation 76: 1111–1117

    Google Scholar 

  12. Cruickshank JM, Neil-Dwyer G, Degaute JP et al (1987) Reduction of stress/catecholamine-induced cardiac necrosis by beta 1- selective blockade. Lancet 1I: 585–589

    Article  Google Scholar 

  13. Stone JG, Foex P, Sear JW et al (1988) Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 68: 495–500

    Article  PubMed  CAS  Google Scholar 

  14. Yeager RA, Moneta GL, Edwards JM et al (1995) Reducing perioperative myocardial infarction following vascular surgery. The potential role of beta-blockade. Arch Surg 130: 869–872

    Article  PubMed  CAS  Google Scholar 

  15. Mangano DT, Layug EL, Wallace A et al (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335: 1713–1720

    Article  CAS  Google Scholar 

  16. Wallace A, Layug B, Tateo I et al (1998) Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 88: 7–17

    Article  PubMed  CAS  Google Scholar 

  17. Mangano DT (1997) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1997; 336: 1453–1454

    Google Scholar 

  18. American College of Physicians (1997) Clinical guideline I. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Intern Med 127: 309–312

    Google Scholar 

  19. Poldermans D, Boersma E, Bax JJ et al (1999) The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341: 1789–1794

    Article  PubMed  CAS  Google Scholar 

  20. Boersma E, Poldermans D, Bax JJ et al (2001) Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 285: 1865–1873

    Article  CAS  Google Scholar 

  21. Raby KE, Brull SJ, Timimi Fetal (1999) The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 88: 477–482

    PubMed  CAS  Google Scholar 

  22. Urban MK, Markowitz SM, Gordon MA et al (2000) Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 90: 1257–1261

    Article  PubMed  CAS  Google Scholar 

  23. Zaugg M, Tagliente T, Lucchinetti E et al (1999) Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 91: 1674–1686

    Article  PubMed  CAS  Google Scholar 

  24. Howell SJ, Sear JW, Foëx P (2001) Perioperative 3-blockade: a useful treatment that should be greeted with cautious enthousiasm. Br J Anaesth 86: 161–164

    Article  PubMed  CAS  Google Scholar 

  25. Sear JW, Howell SJ, Sear YM et al (2001) Intercurrent drug therapy and perioperative cardiovascular mortality in elective and urgent/emergency surgical patients. Br J Anaesth 86: 506–512

    Article  PubMed  CAS  Google Scholar 

  26. Sear JW, Foex P, Howell SJ (2000) Effect of chronic intercurrent medication with beta-adrenoceptor blockade or calcium channel entry blockade on postoperative silent myocardial ischaemia. Br J Anaesth 84: 311–315

    Article  PubMed  CAS  Google Scholar 

  27. Higham HE, Sear JW, Sear YM et al (2000) Does perioperative silent myocardial ischaemia predict long-term adverse outcome in surgical patients. Br J Anaesth 85: 651P–652 P

    Google Scholar 

  28. Howell SJ, Sear YM, Yeates D et al (1999) [3-B lockersand perioperative cardiovascular risk. Br J Anaesth 82: 458 P

    Article  Google Scholar 

  29. Sear JW, George S, Sear YM et al (1999) Can we predict the development of postoperative cardiovascular complications in non-cardiac surgical patients? Br J Anaesth 82 Suppl I: 4

    Google Scholar 

  30. Sutton T, Rock P (1999) Pro: beta-blockers should be used in all patients undergoing vascular surgery. J Cardiothorac Vasc Anesth 13: 490–495

    Article  PubMed  CAS  Google Scholar 

  31. Böttiger BW, Martin E (2000) Prevention of perioperative myocardial ischemia–an update. Anaesthesist 49: 174–186

    Article  PubMed  Google Scholar 

  32. Piriou V, Aouifi A, Lehot JJ (2000) Perioperative beta-blockers. 2. Therapeutic indications. Can J Anaesth 47: 664–672

    Google Scholar 

  33. Jones KG, Powell JT (2000) Slowing the heart saves lives: advantages of perioperative beta-blockade. Br J Surg 87: 689–690

    Article  PubMed  CAS  Google Scholar 

  34. Selzman CH, Miller SA, Zimmerman MA et al (2001) The case for beta-adrenergic blockade as prophylaxis against perioperative cardiovascular morbidity and mortality. Arch Surg 136: 286–290

    Article  PubMed  CAS  Google Scholar 

  35. Lee TH (1999) Reducing cardiac risk in noncardiac surgery. N Engl J Med 341: 1838–1840

    Article  PubMed  CAS  Google Scholar 

  36. Damen J (2001) Perioperatieve myocardischemie en niet-cardiale chirurgie. III. Preventie van myocardischemie en cardiale complicaties: een conceptrichtlijn. NVIC Monitor, 2001: 4–18

    Google Scholar 

  37. Ten Broecke PWC, de Hert SG, Mertens E et al (2003) Effect of preoperative beta-blockade on perioperative mortality in coronary surgery. Br J Anesth 90: 27–31

    Article  Google Scholar 

  38. Rabbani R, Topol EJ (1999) Strategies to achieve coronary arterial plaque stabilization. Cardiovasc Res 41: 402–417

    Article  PubMed  CAS  Google Scholar 

  39. Piriou V, Aouifi A, Lehot JJ (2000) Perioperative beta-blockers. 1. Fundamentals. Can J Anaesth 47: 653–663

    Google Scholar 

  40. Guvendik L, Davies M, Parker DJ (1986) Oral beta-blockade with hypothermic potassium cardioplegia in cardiac surgery. Is there an additive protective effect? Thorac Cardiovasc Surg 34: 25–29

    Article  PubMed  CAS  Google Scholar 

  41. CIBIS II Investigators and Committees (1999) The cardiac insufficiency bisoprolol study. H. (CIBIS-II): a randomised trial. Lancet 353: 9–13

    Article  Google Scholar 

  42. Bühler, FR, Bolli P (1980) The concept of beta-adrenoreceptor blockade in the primary and secondary prevention of cardiac mortality and morbidity. Triangle 19: 35–45

    PubMed  Google Scholar 

  43. Szabo BM, De Graeff PA (2000) Beta-blockers bij hartfalen. Geneesmiddelbulletin 34: 65–70

    Google Scholar 

  44. Yndgaard S, Lippert FK, Berthelsen PG (1997) Are patients chronically treated with beta 1-adrenoceptor antagonists in fact beta-blocked? J Cardiothorac Vasc Anesth 11: 32–36

    Article  PubMed  CAS  Google Scholar 

  45. Milligan G, MacEwan DJ, Mercouris M et al (1997) Inverse agonism at adrenergic and opioid receptors: studies with wild type and constitutively active mutant receptors. Receptors Channels 5: 209–213

    PubMed  CAS  Google Scholar 

  46. Gottlieb S (2001) (3-Blocker response may have gene link. BMJ 322: 814

    Article  Google Scholar 

  47. Hansson L, Zanchetti A, Carruthers SG et al (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351: 1755–1762

    Article  PubMed  CAS  Google Scholar 

  48. Tafreshi MJ, Weinacker AB (1999) Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma. Pharmacotherapy 19: 974–978

    Article  PubMed  CAS  Google Scholar 

  49. Bristow MR (2000) Beta-adrenergic receptor blockade in chronic heart failure. Circulation 101: 558–569

    PubMed  CAS  Google Scholar 

  50. Abraham WT (2000) Beta-blockers: the new standard of therapy for mild heart failure. Arch Intern Med 160: 1237–1247

    Article  PubMed  CAS  Google Scholar 

  51. Hjalmarson A, Goldstein S, Fagerberg B et al (2000) Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 283: 1295–1302

    Article  PubMed  CAS  Google Scholar 

  52. Bonet S, Agusti A, Arnau JM et al (2000) Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients’ characteristics: meta-analysis of clinical trials. Arch Intern Med 160: 621–627

    Article  PubMed  CAS  Google Scholar 

  53. Böttiger BW, Martin E (2001) Beta-Rezeptorenblocker verbessern postoperatives Überleben koronarer Risikopatienten. Dtsch Arzteblatt 198:A 1896–1898

    Google Scholar 

  54. Park KW (2003) Preoperative cardiology consultation. Anesthesiology 98: 754–762

    Article  PubMed  Google Scholar 

  55. Auerbach AD, Goldman L (2002) Beta-Blockers and reduction of cardiac events in noncardiac surgery (scientific review). JAMA 287: 1435–1444

    Article  PubMed  CAS  Google Scholar 

  56. Shammash JB, Trost JC, Gold JM et al (2001) Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 141: 148–153

    Article  PubMed  CAS  Google Scholar 

  57. Martinez EA, Kim LJ, Faraday N et al (2000) Postoperative use of beta-blockers reduces mortality at one year in high risk surgical patients. ASA Abs: A-238

    Google Scholar 

  58. Fonarow GC, Gawlinski A, Moughrabi S et al (2001) Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program ( CHAMP ). Am J Cardiol 87: 819–822

    Article  PubMed  CAS  Google Scholar 

  59. Armanious S, Wong DT, Etchells E et al (2003) Successful implementation of perioperative beta-blockade utilizing a multidisciplinary approach. Can J Anaesth 50: 131–136

    Article  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Italia, Milano

About this paper

Cite this paper

Klimek, M. (2004). Beta blockers in premedication of the cardiac patient — a must in 2003?!. In: Gullo, A. (eds) Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.. Springer, Milano. https://doi.org/10.1007/978-88-470-2189-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2189-1_8

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0235-7

  • Online ISBN: 978-88-470-2189-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics